Similar articles

• Treatment of myelodysplastic syndromes with hematopoietic growth factors.

  Ganser A, Hoelzer D. Ganser A, et al. Hematol Oncol Clin North Am. 1992 Jun;6(3):633-53. Hematol Oncol Clin North Am. 1992. PMID: 1377194 Review.
• [Clinical use of hematopoietic growth factors].

  Krusius T. Krusius T. Duodecim. 1990;106(7):547-9. Duodecim. 1990. PMID: 1727024 Review. Finnish. No abstract available.
• Treatment of myelodysplastic syndromes with hemopoietic growth factors.

  Greenberg PL. Greenberg PL. Semin Oncol. 1992 Feb;19(1):106-14. Semin Oncol. 1992. PMID: 1371018 Review. No abstract available.
• Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.

  Ganser A, Hoelzer D. Ganser A, et al. Semin Hematol. 1996 Jul;33(3):186-95. Semin Hematol. 1996. PMID: 8819229 Review. No abstract available.
• The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.

  Rossi Ferrini P, Santini V, Ciolli S, Grossi A, Leoni F, Rafanelli D, Vannucchi AM. Rossi Ferrini P, et al. Hematol Oncol. 1993;11 Suppl 1:32-5. Hematol Oncol. 1993. PMID: 7683622 Review. No abstract available.